RUBY
Vanguard Group’s Rubius Therapeutics, Inc RUBY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,676,669
| Closed | -$293K | – | 4610 |
|
|
2022
Q4 | $293K | Sell |
1,676,669
-28,619
| -2% | -$5.01K | ﹤0.01% | 4228 |
|
|
2022
Q3 | $740K | Sell |
1,705,288
-231,905
| -12% | -$101K | ﹤0.01% | 4092 |
|
|
2022
Q2 | $1.65M | Sell |
1,937,193
-393,532
| -17% | -$335K | ﹤0.01% | 3891 |
|
|
2022
Q1 | $12.8M | Sell |
2,330,725
-915,916
| -28% | -$5.05M | ﹤0.01% | 3020 |
|
|
2021
Q4 | $31.4M | Buy |
3,246,641
+11,634
| +0.4% | +$113K | ﹤0.01% | 2614 |
|
|
2021
Q3 | $57.8M | Sell |
3,235,007
-7,396
| -0.2% | -$132K | ﹤0.01% | 2287 |
|
|
2021
Q2 | $79.1M | Buy |
3,242,403
+143,801
| +5% | +$3.51M | ﹤0.01% | 2118 |
|
|
2021
Q1 | $82.1M | Buy |
3,098,602
+689,847
| +29% | +$18.3M | ﹤0.01% | 2061 |
|
|
2020
Q4 | $18.3M | Buy |
2,408,755
+39,481
| +2% | +$300K | ﹤0.01% | 2681 |
|
|
2020
Q3 | $11.9M | Sell |
2,369,274
-789,856
| -25% | -$3.96M | ﹤0.01% | 2705 |
|
|
2020
Q2 | $18.9M | Buy |
3,159,130
+154,697
| +5% | +$925K | ﹤0.01% | 2456 |
|
|
2020
Q1 | $13.4M | Buy |
3,004,433
+15,776
| +0.5% | +$70.2K | ﹤0.01% | 2481 |
|
|
2019
Q4 | $28.4M | Buy |
2,988,657
+84,826
| +3% | +$806K | ﹤0.01% | 2366 |
|
|
2019
Q3 | $22.8M | Buy |
2,903,831
+178,114
| +7% | +$1.4M | ﹤0.01% | 2423 |
|
|
2019
Q2 | $42.9M | Buy |
2,725,717
+614,759
| +29% | +$9.67M | ﹤0.01% | 2185 |
|
|
2019
Q1 | $38.2M | Buy |
2,110,958
+1,116,709
| +112% | +$20.2M | ﹤0.01% | 2225 |
|
|
2018
Q4 | $16M | Buy |
994,249
+22,217
| +2% | +$357K | ﹤0.01% | 2540 |
|
|
2018
Q3 | $23.3M | Buy |
+972,032
| New | +$23.3M | ﹤0.01% | 2512 |
|